Randomized clinical trial of endovenous laser ablation versus steam ablation (LAST trial) for great saphenous varicose veins
- PMID:24981585
- DOI: 10.1002/bjs.9580
Randomized clinical trial of endovenous laser ablation versus steam ablation (LAST trial) for great saphenous varicose veins
Erratum in
- Br J Surg. 2014 Oct;101(11):1484
Abstract
Background: The aim was to compare endovenous laser ablation (EVLA) and endovenous steam ablation (EVSA) for great saphenous varicose veins in a non-inferiority study.
Methods: Patients with primary great saphenous vein reflux were randomized to EVLA (940 nm) or EVSA (SVS™). Primary outcomes were treatment success (vein obliteration or abolition of reflux) [corrected] at 52 weeks, and Venous Clinical Severity Score (VCSS) at 12 weeks. Secondary outcomes were pain, satisfaction with treatment, duration of analgesia use and days lost from daily activities, changes in Aberdeen Varicose Vein Questionnaire (AVVQ) and EQ-5D™ scores after 12 weeks, and complications at 2 and 12 weeks.
Results: A total of 227 legs were treated (EVSA, 117; EVLA, 110); 36 legs treated with EVSA received a low dose and the remaining 81 a higher dose. At 1 year, the treatment success rate after high-dose EVSA was not inferior to that of EVLA: 92 (95 per cent confidence interval (c.i.) 86 to 98) versus 96 (92 to 100) per cent respectively. Changes in VCSS after 12 weeks were similar: -2·69 (95 per cent c.i. -2·34 to -3·04) and -2·51 (-2·10 to -2·93). AVVQ, EQ-5D™ and EQ VAS scores improved equally 12 weeks after both treatments. Patients treated with EVSA reported less postprocedural pain, fewer days of analgesia use, were more satisfied with therapy, and had a shorter convalescence. Complication rates were comparable.
Conclusion: The 1-year treatment success of high-dose EVSA was not inferior to that of EVLA. Several secondary outcomes were in favour of EVSA. Registration numberNCT02046967 (http://www.clinicaltrials.gov).
© 2014 BJS Society Ltd. Published by John Wiley & Sons Ltd.
Similar articles
- Randomized clinical trial of VNUS ClosureFAST radiofrequency ablation versus laser for varicose veins.Shepherd AC, Gohel MS, Brown LC, Metcalfe MJ, Hamish M, Davies AH.Shepherd AC, et al.Br J Surg. 2010 Jun;97(6):810-8. doi: 10.1002/bjs.7091.Br J Surg. 2010.PMID:20473992Clinical Trial.
- Five-year results of a randomized clinical trial of conventional surgery, endovenous laser ablation and ultrasound-guided foam sclerotherapy in patients with great saphenous varicose veins.van der Velden SK, Biemans AA, De Maeseneer MG, Kockaert MA, Cuypers PW, Hollestein LM, Neumann HA, Nijsten T, van den Bos RR.van der Velden SK, et al.Br J Surg. 2015 Sep;102(10):1184-94. doi: 10.1002/bjs.9867. Epub 2015 Jul 1.Br J Surg. 2015.PMID:26132315Clinical Trial.
- Randomized clinical trial comparing endovenous laser ablation with surgery for the treatment of primary great saphenous varicose veins.Darwood RJ, Theivacumar N, Dellagrammaticas D, Mavor AI, Gough MJ.Darwood RJ, et al.Br J Surg. 2008 Mar;95(3):294-301. doi: 10.1002/bjs.6101.Br J Surg. 2008.PMID:18278775Clinical Trial.
- Endovenous ablation therapy (laser or radiofrequency) or foam sclerotherapy versus conventional surgical repair for short saphenous varicose veins.Paravastu SC, Horne M, Dodd PD.Paravastu SC, et al.Cochrane Database Syst Rev. 2016 Nov 29;11(11):CD010878. doi: 10.1002/14651858.CD010878.pub2.Cochrane Database Syst Rev. 2016.PMID:27898181Free PMC article.Review.
- Editor's Choice - Five Year Results of Great Saphenous Vein Treatment: A Meta-analysis.Hamann SAS, Giang J, De Maeseneer MGR, Nijsten TEC, van den Bos RR.Hamann SAS, et al.Eur J Vasc Endovasc Surg. 2017 Dec;54(6):760-770. doi: 10.1016/j.ejvs.2017.08.034. Epub 2017 Oct 14.Eur J Vasc Endovasc Surg. 2017.PMID:29033337Review.
Cited by
- [Varicosis-Current treatment concepts].Lisii C, Heckenkamp J.Lisii C, et al.Chirurgie (Heidelb). 2024 May;95(5):415-426. doi: 10.1007/s00104-024-02063-4. Epub 2024 Apr 10.Chirurgie (Heidelb). 2024.PMID:38597983German.
- Interventions for great saphenous vein incompetence.Whing J, Nandhra S, Nesbitt C, Stansby G.Whing J, et al.Cochrane Database Syst Rev. 2021 Aug 11;8(8):CD005624. doi: 10.1002/14651858.CD005624.pub4.Cochrane Database Syst Rev. 2021.PMID:34378180Free PMC article.Review.
- A state-of-the-art review of quality-of-life assessment in venous disease.Cleman J, Xia K, Haider M, Nikooie R, Scierka L, Romain G, Attaran RR, Grimshaw A, Mena-Hurtado C, Smolderen KG.Cleman J, et al.J Vasc Surg Venous Lymphat Disord. 2024 Jul;12(4):101725. doi: 10.1016/j.jvsv.2023.101725. Epub 2023 Dec 19.J Vasc Surg Venous Lymphat Disord. 2024.PMID:38128828Free PMC article.Review.
- S2k guidelines: diagnosis and treatment of varicose veins.Pannier F, Noppeney T, Alm J, Breu FX, Bruning G, Flessenkämper I, Gerlach H, Hartmann K, Kahle B, Kluess H, Mendoza E, Mühlberger D, Mumme A, Nüllen H, Rass K, Reich-Schupke S, Stenger D, Stücker M, Schmedt CG, Schwarz T, Tesmann J, Teßarek J, Werth S, Valesky E.Pannier F, et al.Hautarzt. 2022 May;73(Suppl 1):1-44. doi: 10.1007/s00105-022-04977-8. Epub 2022 Apr 19.Hautarzt. 2022.PMID:35438355Free PMC article.Review.No abstract available.
- [Minimally invasive catheters in varicose vein treatment : New gold standard?].Böhler K.Böhler K.Dermatologie (Heidelb). 2023 Mar;74(3):163-170. doi: 10.1007/s00105-023-05113-w. Epub 2023 Feb 22.Dermatologie (Heidelb). 2023.PMID:36811641Free PMC article.Review.German.
Publication types
MeSH terms
Substances
Associated data
Related information
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical